🟢 Omada Health is trading 8.5% up in pre-market after first GAAP-profitable quarter

Omada Health is trading 8.5% up at $21.20 after its August 6, 2026 earnings report delivered $87.8 million in revenue, record margins, and its first GAAP-profitable quarter.

• Management raised full-year revenue guidance to $334 million–$340 million and adjusted EBITDA guidance to $21 million–$27 million.
• The pre-market move extends the favorable post-earnings reaction; CEO transition news adds context.
• Healthcare’s 1.27% gain provides supportive sector context, though the reaction is company-specific.